Home › Funds › Commodore Capital LP › EYPT
Commodore Capital LP position in EYPT
EYEPOINT INC · Industrials
Commodore Capital LP reported holding 4,600,000 shares of EYPT (EYEPOINT INC) in its Q2 2026 13F filing — a position valued at US$65.8M, representing 3.92% of its reported portfolio and ranking #10 among its reported holdings. Commodore Capital LP has disclosed EYPT holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Commodore Capital LP's EYPT position evolved
Commodore Capital LP first disclosed a stake in EYPT in Q1 2026 at 2,825,000 shares (US$36.4M). The position peaked in Q2 2026 at 4,600,000 shares, worth US$65.8M. Across 2 filings, Commodore Capital LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 4,600,000 shares valued at US$65.8M — an increase of 1,775,000 shares quarter over quarter.. Notable position changes include a 63% increase in Q2 2026 (shares fell 77% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 2.83M | $36.41M | New |
| Q2 2026 | 4.60M | $65.78M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EYPT and 13F data
EYPT (EYEPOINT INC) is a Industrials company. 42 other funds we track also report a position in EYPT — the largest reported positions include MONTANOVA CAPITAL, LLC (US$118.6M), Cormorant Asset Management, LP (US$100.1M), Paradigm Biocapital Advisors LP (US$41.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EYPT
- MONTANOVA CAPITAL, LLC 8.30M sh · $118.64M · Q2 2026
- Cormorant Asset Management, LP 7.00M sh · $100.10M · Q2 2026
- Paradigm Biocapital Advisors LP 2.89M sh · $41.33M · Q2 2026
- PERCEPTIVE ADVISORS LLC 2.00M sh · $28.60M · Q2 2026
- Parkman Healthcare Partners LLC 1.29M sh · $18.42M · Q2 2026
- Essex Woodlands Management, Inc. 1.08M sh · $15.51M · Q2 2026
- 5AM Venture Management, LLC 1.05M sh · $15.02M · Q2 2026
- Rosalind Advisors, Inc. 988.23K sh · $14.13M · Q2 2026
- Artia Global Partners LP 767.10K sh · $10.97M · Q2 2026
- Blue Owl Capital Holdings LP 762.59K sh · $10.91M · Q2 2026
- Patient Square Capital LP 720.00K sh · $10.30M · Q2 2026
- Principia Wealth Advisory, LLC 649.94K sh · $9.29M · Q2 2026
More on Commodore Capital LP
FAQ
How long has Commodore Capital LP held EYPT?
Commodore Capital LP has disclosed EYPT holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Commodore Capital LP's current position in EYPT?
As of Q2 2026, Commodore Capital LP holds 4.60M shares of EYPT (EYEPOINT INC), valued at $65.78M, representing 3.92% of its reported portfolio and ranking #10.
Has Commodore Capital LP been buying or selling EYPT?
In the latest 13F filing (Q2 2026), Commodore Capital LP increased its position in EYPT. The position peaked in Q2 2026 at 4.60M shares.
Which other funds hold EYPT?
Other major institutional holders of EYPT include MONTANOVA CAPITAL, LLC, Cormorant Asset Management, LP, Paradigm Biocapital Advisors LP, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.